Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 195

Similar articles for PubMed (Select 15286067)

1.

Testing for diabetes in hospitalised patients prescribed antipsychotic drugs.

Taylor D, Young C, Esop R, Paton C, Walwyn R.

Br J Psychiatry. 2004 Aug;185:152-6.

2.

Assessment of antipsychotic-related risk of diabetes mellitus in a Medicaid psychosis population: sensitivity to study design.

Gianfrancesco F, Pesa J, Wang RH, Nasrallah H.

Am J Health Syst Pharm. 2006 Mar 1;63(5):431-41.

PMID:
16484517
3.

Atypical antipsychotic drugs and diabetes mellitus in a large outpatient population: a retrospective cohort study.

Østbye T, Curtis LH, Masselink LE, Hutchison S, Wright A, Dans PE, Schulman KA, Krishnan RR.

Pharmacoepidemiol Drug Saf. 2005 Jun;14(6):407-15.

PMID:
15372671
4.

Relationship between antipsychotic medication treatment and new cases of diabetes among psychiatric inpatients.

Citrome L, Jaffe A, Levine J, Allingham B, Robinson J.

Psychiatr Serv. 2004 Sep;55(9):1006-13.

PMID:
15345760
5.

[Therapy with antipsychotic drugs as a risk factor for diabetes in schizophrenia: a case-control study].

Rubio G, Gómez-de-la-Cámara A, Ledesma F, Burón JA, Rodríguez-Morales A, Martínez-Junquera G; Grupo Español para el Estudio de la Diabetes en Pacientes Esquizofrénicos.

Med Clin (Barc). 2006 Apr 1;126(12):441-4. Spanish.

PMID:
16620729
6.

Antipsychotic exposure and type 2 diabetes among patients with schizophrenia: a matched case-control study of California Medicaid claims.

Lambert BL, Chou CH, Chang KY, Tafesse E, Carson W.

Pharmacoepidemiol Drug Saf. 2005 Jun;14(6):417-25.

PMID:
15786516
7.

Incidence of newly diagnosed diabetes attributable to atypical antipsychotic medications.

Leslie DL, Rosenheck RA.

Am J Psychiatry. 2004 Sep;161(9):1709-11.

PMID:
15337666
8.

Risk of diabetes mellitus associated with atypical antipsychotic use among Medicaid patients with bipolar disorder: a nested case-control study.

Guo JJ, Keck PE Jr, Corey-Lisle PK, Li H, Jiang D, Jang R, L'Italien GJ.

Pharmacotherapy. 2007 Jan;27(1):27-35.

PMID:
17192159
9.

Risk of diabetes mellitus associated with atypical antipsychotic use among patients with bipolar disorder: A retrospective, population-based, case-control study.

Guo JJ, Keck PE Jr, Corey-Lisle PK, Li H, Jiang D, Jang R, L'Italien GJ.

J Clin Psychiatry. 2006 Jul;67(7):1055-61.

PMID:
16889448
10.

Incident diabetes associated with antipsychotic use in the United Kingdom general practice research database.

Kornegay CJ, Vasilakis-Scaramozza C, Jick H.

J Clin Psychiatry. 2002 Sep;63(9):758-62.

PMID:
12363114
11.

[Schizophrenia, diabetes mellitus and antipsychotics].

Gury C.

Encephale. 2004 Jul-Aug;30(4):382-91. Review. French.

PMID:
15538314
12.

Atypical antipsychotics and new onset diabetes mellitus. An overview of the literature.

Cohen D.

Pharmacopsychiatry. 2004 Jan;37(1):1-11. Review.

PMID:
14750042
13.

Randomised controlled trials of conventional antipsychotic versus new atypical drugs, and new atypical drugs versus clozapine, in people with schizophrenia responding poorly to, or intolerant of, current drug treatment.

Lewis SW, Davies L, Jones PB, Barnes TR, Murray RM, Kerwin R, Taylor D, Hayhurst KP, Markwick A, Lloyd H, Dunn G.

Health Technol Assess. 2006 May;10(17):iii-iv, ix-xi, 1-165.

14.

Undiagnosed impaired fasting glucose and diabetes mellitus amongst inpatients receiving antipsychotic drugs.

Taylor D, Young C, Mohamed R, Paton C, Walwyn R.

J Psychopharmacol. 2005 Mar;19(2):182-6.

PMID:
15728440
15.

Undiagnosed hyperglycemia in patients treated with atypical antipsychotics.

Sernyak MJ, Gulanski B, Rosenheck R.

J Clin Psychiatry. 2005 Nov;66(11):1463-7.

PMID:
16420085
16.

Treatment of schizophrenia with antipsychotics in Norwegian emergency wards, a cross-sectional national study.

Kroken RA, Johnsen E, Ruud T, Wentzel-Larsen T, Jørgensen HA.

BMC Psychiatry. 2009 May 16;9:24. doi: 10.1186/1471-244X-9-24.

17.

Differential effects of antipsychotic agents on the risk of development of type 2 diabetes mellitus in patients with mood disorders.

Gianfrancesco F, Grogg A, Mahmoud R, Wang RH, Meletiche D.

Clin Ther. 2003 Apr;25(4):1150-71.

PMID:
12809963
18.

First- v. second-generation antipsychotics and risk for diabetes in schizophrenia: systematic review and meta-analysis.

Smith M, Hopkins D, Peveler RC, Holt RI, Woodward M, Ismail K.

Br J Psychiatry. 2008 Jun;192(6):406-11. doi: 10.1192/bjp.bp.107.037184. Review.

19.

Elevated hemoglobin A1c as a possible indicator of diabetes mellitus and diabetic ketoacidosis in schizophrenia patients receiving atypical antipsychotics.

Henderson DC, Cagliero E, Copeland PM, Louie PM, Borba CP, Fan X, Freudenreich O, Goff DC.

J Clin Psychiatry. 2007 Apr;68(4):533-41.

PMID:
17474808
20.

Data on diabetes from the French cohort study in schizophrenia.

Philippe A, Vaiva G, Casadebaig F.

Eur Psychiatry. 2005 Dec;20 Suppl 4:S340-4.

PMID:
16459248
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk